Novartis AG
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $74.17B | $8.86B |
| FY2018 | — | $74.29B | $13.27B |
| FY2019 | — | $55.47B | $11.11B |
| FY2020 | — | $56.60B | $9.66B |
| FY2021 | — | $67.66B | $12.41B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $74.17B | $8.86B |
| FY2018 | — | $74.29B | $13.27B |
| FY2019 | — | $55.47B | $11.11B |
| FY2020 | — | $56.60B | $9.66B |
| FY2021 | — | $67.66B | $12.41B |